Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1959 2
1960 1
1961 2
1962 1
1963 1
1964 5
1965 3
1966 1
1968 1
1969 7
1970 2
1971 1
1972 3
1973 3
1974 7
1975 2
1976 2
1977 5
1978 10
1979 8
1980 14
1981 15
1982 11
1983 13
1984 17
1985 19
1986 24
1987 11
1988 13
1989 16
1990 16
1991 25
1992 13
1993 26
1994 31
1995 26
1996 20
1997 30
1998 37
1999 33
2000 43
2001 53
2002 55
2003 71
2004 88
2005 116
2006 111
2007 126
2008 134
2009 137
2010 184
2011 218
2012 250
2013 298
2014 364
2015 396
2016 415
2017 521
2018 528
2019 672
2020 881
2021 972
2022 1196
2023 1166
2024 342

Text availability

Article attribute

Article type

Publication date

Search Results

8,836 results

Results by year

Filters applied: . Clear all
Page 1
Age-Induced Accumulation of Succinate Promotes Cardiac Fibrogenesis.
Wang Z, Yang S, Ping Z, Li Y, Jiang T, Zheng X, Zhang Z, Wang G, Liu Z, Sun H, Zhang Q, Zhang H, Gao Y, Feng Y, Liu X, Han L, Lin S, Zhang X, Song M, Liu T, Tang M, Liu C, Xie H, Ruan G, Yang M, Chen Y, Yuan X, Wang D, Zhang X, Wang C, Jiang Z, Xu Y, Chen L, Deng L, Wu B, Zhou D, Cao X, Shi H, Sun T. Wang Z, et al. Among authors: sun t. Circ Res. 2023 Dec 19;0(1):1-23. doi: 10.1161/CIRCRESAHA.123.323651. Epub 2023 Dec 19. Circ Res. 2023. PMID: 38112098 Free article. Retracted. No abstract available.
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Passaro A, et al. Among authors: sun t. Ann Oncol. 2024 Jan;35(1):77-90. doi: 10.1016/j.annonc.2023.10.117. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879444 Free article. Clinical Trial.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: sun t. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons.
Zhao S, Lu J, Pan B, Fan H, Byrum SD, Xu C, Kim A, Guo Y, Kanchi KL, Gong W, Sun T, Storey AJ, Burkholder NT, Mackintosh SG, Kuhlers PC, Edmondson RD, Strahl BD, Diao Y, Tackett AJ, Raab JR, Cai L, Song J, Wang GG. Zhao S, et al. Among authors: sun t. Nature. 2023 Nov;623(7987):633-642. doi: 10.1038/s41586-023-06688-z. Epub 2023 Nov 8. Nature. 2023. PMID: 37938770
Advanced nano-based strategies for mRNA tumor vaccine.
Qu Y, Xu J, Zhang T, Chen Q, Sun T, Jiang C. Qu Y, et al. Among authors: sun t. Acta Pharm Sin B. 2024 Jan;14(1):170-189. doi: 10.1016/j.apsb.2023.07.025. Epub 2023 Jul 29. Acta Pharm Sin B. 2024. PMID: 38239240 Free PMC article. Review.
White matter changes in Parkinson's disease.
Yang K, Wu Z, Long J, Li W, Wang X, Hu N, Zhao X, Sun T. Yang K, et al. Among authors: sun t. NPJ Parkinsons Dis. 2023 Oct 31;9(1):150. doi: 10.1038/s41531-023-00592-z. NPJ Parkinsons Dis. 2023. PMID: 37907554 Free PMC article. Review.
8,836 results